Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

U.S. Supreme Court Oral Arguments

A case in which the Court will decide (1) when a generic drug manufacturer excludes a patented use from its label, whether it still be liable for inducing infringement if it calls its product a “generic version” of the b...View more